Common ADHD drug tested as potential relief for debilitating MS fatigue
NCT ID NCT02286557
Summary
This study tested whether methylphenidate, a stimulant medication commonly used for ADHD, could help reduce the severe cognitive fatigue experienced by most people with Multiple Sclerosis (MS). In this trial, 36 adults with MS tried both the drug and a placebo, with neither they nor the researchers knowing which they received at the time. The goal was to provide solid evidence for doctors on whether this already-approved medication could be a helpful treatment for this common and disabling MS symptom.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATIGUE IN MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kessler Foundation
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.